<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03412344</url>
  </required_header>
  <id_info>
    <org_study_id>CH-HUR-004</org_study_id>
    <nct_id>NCT03412344</nct_id>
  </id_info>
  <brief_title>Factors Influencing Cancer Patients Participation in Clinical Trials in China.</brief_title>
  <official_title>Assessing Knowledge and Affecting Factors Associated With Cancer Patients Participation in Clinical Trials in China.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Academy of Medical Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research studies factors affecting Chinese patient participation in cancer clinical
      trials and their knowledge regarding clinical trials. The investigators design this study to
      determining how patients makes decisions about participating in a clinical trial and know
      about patients' attitude toward clinical trials. The investigators aim to find ways to make
      cancer clinical trials in China more efficient and satisfied patients participating in
      clinical trials in China.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The patient related factors and the doctor related factors that influence patient decision regarding participation in a cancer clinical trial will be explored by questionnaire.</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oncology patients' understanding and attitude of clinical trials towards cancer clinical research will be evaluated by questionnaire.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The actual experience of participants in a cancer clinical trial will be investigated by questionnaire.</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Chinese patients with a diagnosis of cancer who have joined cancer clinical trial.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of malignancy

          -  Aged 18 years or older

          -  Ability to understand and complete the questionnaire independently or with the help of
             a relative or staff member of the oncology department

          -  Patients have been consented to join an oncology treatment clinical study and have
             begun active treatment of an oncology clinical trial

        Exclusion Criteria:

        â€¢ Not meeting all eligibility criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Yuankai Shi, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Academy of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shiyu Jiang, MD</last_name>
    <phone>+86 13121700970</phone>
    <email>309615685@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cancer Institute/Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuankai Kai, PhD</last_name>
      <phone>+86 10 87788293</phone>
      <email>cancergcp@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2017</study_first_submitted>
  <study_first_submitted_qc>January 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 26, 2018</study_first_posted>
  <last_update_submitted>January 20, 2018</last_update_submitted>
  <last_update_submitted_qc>January 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Shi Yuankai</investigator_full_name>
    <investigator_title>Professor of medical oncology Deputy Director National Cancer Center Vice President Cancer Hospital Chinese Academy of Medical Sciences(CAMS) &amp; Peking Union Medical College(PUMC)</investigator_title>
  </responsible_party>
  <keyword>clinical trial</keyword>
  <keyword>patient</keyword>
  <keyword>questionnaire</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

